We have also chosen C-reactive protein (CRP), cancer antigen (CA)125, CA153, carcinoembryonic antigen (CEA), D-dimer (D-D), fibrinogen (FIB), international normalized ratio (INR), fibrin degradation product (FDP), white blood cell (W), red blood cell (R), hemoglobin (Hb), neutrophil (N), lymphocyte (L), monocyte (M), eosinophils (E), basophils (B), and platelet (P) counts as parameters to evaluate the inflammatory status of breast cancer patients. This evidence concerns the gene CRP and breast cancer.